In mice, lost sleep worsened progressive MS-like disease

Credibility

Interest

Share:1 min read

Key Takeaway

In mice, disrupted sleep worsened an MS-like disease, while results from an earlier trial linked a Mediterranean diet to improved MS symptoms.

What They Found

In mice with a relapsing MS-like disease, production of certain immune cells rose before symptoms began and during recovery periods. In mice with a progressive MS-like disease, this activity changed differently across the spine, leg bone, and spleen. Disrupted sleep and unhealthy blood fat and heart-related conditions worsened symptoms in the mice with progressive disease. Blocking a signal that helps make these immune cells prevented that worsening. Results from an earlier trial linked a Mediterranean diet to less of this cell production and improved MS symptoms.

Who Should Care and Why

This study mainly examined mice with relapsing or progressive MS-like diseases. It also reported results from an earlier trial involving people with MS. The mouse findings connect disrupted sleep and unhealthy blood fat and heart-related conditions with worse progressive disease. They show that immune cell production changed with disease stage and body location. The earlier trial results connect a Mediterranean diet with changes in immune cell production and MS symptoms.

Important Considerations

You should know that most findings came from mice, not people. The abstract does not give the number of mice or people studied. It does not show whether blocking the immune signal helps people with MS.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research Living with MS

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News